World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
57590
World Ranking
7511
National Ranking
3922

Overview

Ross S. Berkowitz is affiliated with Harvard Medical School in the United States. Their research primarily focuses on medicine, with particular emphasis on public health, environmental and occupational health, pediatrics, perinatology, child health, surgery, reproductive medicine, and oncology. The scientist's work covers important topics such as gestational trophoblastic disease studies, prenatal screening and diagnostics, ectopic pregnancy diagnosis and management, ovarian cancer diagnosis and treatment, congenital diaphragmatic hernia studies, maternal and fetal healthcare, and intraperitoneal and appendiceal malignancies.

Berkowitz has published extensively in several academic venues. Frequent publication venues include:

  • Gynecologic Oncology
  • International Journal of Gynecological Cancer
  • Hematology/Oncology Clinics of North America
  • Clinics
  • The Lancet Oncology

The scientist's recent papers illustrate their involvement in reproductive and oncological conditions. Selected recent papers include:

  • "Diagnosis and management of gestational trophoblastic disease: 2021 update" (2021), International Journal of Gynecology & Obstetrics
  • "Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer" (2020), Cancer Research
  • "Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study" (2020), Gynecologic Oncology
  • "Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study" (2021), The Lancet Oncology
  • "Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease" (2021), Best Practice & Research Clinical Obstetrics & Gynaecology

Berkowitz frequently collaborates with other researchers. Key collaborators include Neil S. Horowitz, Kevin M. Elias, Antônio Braga, Izildinha Maestá, and Michael J. Worley. The number of joint publications with these colleagues ranges from 13 to 69, indicating ongoing cooperative research efforts.

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

    R C Bast;T L Klug;E St John;E Jenison

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

    David W. Kindelberger;Yonghee Lee;Alexander Miron;Michelle S. Hirsch

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Gestational trophoblastic disease

    Michael J Seckl;Neil J Sebire;Ross S Berkowitz

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes.

    P J Smith;L S Wise;R Berkowitz;C Wan

  • Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer

    Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong

  • Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk Reduction

    Michael J. Callahan;Christopher P. Crum;Fabiola Medeiros;David W. Kindelberger

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Fluoxetine in posttraumatic stress disorder.

    B A van der Kolk;D Dreyfuss;M Michaels;D Shera

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry

    Bin Ye;Daniel W. Cramer;Steven J. Skates;Steven P. Gygi

  • Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology

    Samuel C. Mok;Julie Chao;Steven Skates;Kwong Kwok Wong

  • Dissociative disorders in psychiatric inpatients.

    G. N. Saxe;B. A. van der Kolk;R. Berkowitz;G. Chinman

  • Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

    Shannon M. McAuliffe;Stefanie L. Morgan;Gregory A. Wyant;Lieu T. Tran

  • Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

    Joan Montero;Kristopher A. Sarosiek;Joseph D. DeAngelo;Ophélia Maertens

Frequent Co-Authors

Samuel C. Mok
Samuel C. Mok The University of Texas MD Anderson Cancer Center
Christopher P. Crum
Christopher P. Crum Brigham and Women's Hospital
Daniel W. Cramer
Daniel W. Cramer Brigham and Women's Hospital
Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Deborah J. Anderson
Deborah J. Anderson Boston University
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Ellice Lieberman
Ellice Lieberman Brigham and Women's Hospital
Ronny Drapkin
Ronny Drapkin University of Pennsylvania
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open diverse career opportunities for those interested in medicine but seeking flexible or specialized paths. Online programs now make it easier to advance your education while balancing work or personal commitments.

For nurses aiming to specialize in mental health, there are shortest post master's pmhnp online programs that quickly prepare you for advanced roles in psychiatric care. If you're interested in the business side of healthcare, a health care administration degree online provides foundational skills for management positions in hospitals or clinics.

Those seeking leadership roles often pursue graduate studies. You can find the cheapest online mha programs to earn your master's degree in healthcare administration without a large financial burden. Alternatively, nurses looking to achieve the highest level of clinical practice might consider the cheapest bsn to dnp programs.

These online degree pathways cater to a range of interests in the medical field, helping you build a rewarding career on your own schedule and at a manageable cost.

Best Scientists Citing Ross S. Berkowitz

Trending Scientists

Recently Published Articles